MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 840 participants.
Also called NCT03135275
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 840 participants
- Sponsor
- Registry
-
NCT03135275
-
- Other papers using this trial's data
- Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trial
- Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT03135275. Randomized; no masking; primary purpose treatment. Start 2016-10 (actual); primary completion 2023-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial
- Acronym
- MULTISTARS AMI
- Condition
- ST-elevation Myocardial Infarction
- Condition
- Multivessel Coronary Disease
- Intervention (Procedure)
- Staged complete PCI (percutaneous coronary intervention)
- Intervention (Procedure)
- Immediate complete PCI
- Intervention (Device)
- Synergy™ stent
- Lead sponsor
- University of Zurich
Record details
- Record id
cardio:ct-nct03135275- Content hash
b49080745a7f8ab5a8706747426740a4c93e96386ae2ad3c6b7f1a072532968e